Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference.

Author: AgacheIoana, AmaralRita, AnsoteguiIgnacio J, AntoJosep M, BedbrookAnna, BergmannKarl C, Bosnic-AnticevichSinthia, BousquetJean, BrozekJan, BrussinoLuisa, CanonicaG Walter, CardonaVictoria, Carreiro-MartinsPedro, CasaleThomas, CecchiLorenzo, ChivatoTomas, ChuDerek K, CingiCemal, CostaElísio M, CruzAlvaro A, CzarlewskiWienczyslawa, Del GiaccoStefano, DevillierPhilippe, EklundPatrik, FokkensWytske J, FonsecaJoao A, GemiciogluBilun, HaahtelaTari, IspayevaZhanat, IvancevichJuan Carlos, JutelMarek, KaidashevIgor, KhaitovMusa, KlimekLudger, KraxnerHelga, KunaPiotr, KvedarieneVioleta, Larenas-LinnemannDesirée, LauneDaniel, LipworthBrian, LouisRenaud, MakrisMichael, MontiRiccardo, Morais-AlmeidaMario, MullolJoaquim, MösgesRalph, NiedoszytkoMarek, OkamotoYoshitaka, PapadopoulosNikolaos G, PatellaVincenzo, PfaarOliver, Pham-ThiNhân, RegateiroFrederico S, ReitsmaSietze, RouadiPhilip W, SamolinskiBoleslaw, SastreJoaquin, SchünemannHolger J, SheikhAziz, Sousa-PintoBernardo, SovaMilan, Sá-SousaAna, Taborda-BarataLuis, Todo-BomAna, Toppila-SalmiSanna, TsiligianniIoanna, ValiulisArunas, VandenplasOlivier, VenturaMaria Teresa, VieiraRafael José, WallaceDana, WasermanSusan, YorganciogluArzu, ZidarnMihaela, ZuberbierTorsten

Paper Details 
Original Abstract of the Article :
Different treatments exist for allergic rhinitis (AR), including pharmacotherapy and allergen immunotherapy (AIT), but they have not been compared using direct patient data (i.e., "real-world data"). We aimed to compare AR pharmacological treatments on (i) daily symptoms, (ii) frequency of use in co...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/all.15371

データ提供:米国国立医学図書館(NLM)

Allergic Rhinitis: A Comparative Study of Treatment Options

Allergic rhinitis (AR) is a common condition that affects millions of people worldwide. This research compares the effectiveness of different treatments for AR, including pharmacotherapy and allergen immunotherapy (AIT), using real-world patient data.

The authors analyzed data from the MASK-air® registry, a large database of patients with AR. They compared different pharmacological treatments based on daily symptoms, frequency of co-medication use, and visual analogue scales (VASs) on allergy symptom control. The authors also investigated the impact of AIT on symptom control. Their analysis revealed that different treatments had varying effects on symptom control, and the effectiveness of AIT varied depending on the severity of AR.

Understanding the Landscape of AR Treatments

This research provides valuable insights into the real-world effectiveness of different AR treatments. The analysis of the MASK-air® registry offers a comprehensive view of treatment outcomes, highlighting the varying degrees of effectiveness of different therapies. The findings can inform clinical decision-making and personalize treatment plans for individuals with AR.

Managing AR: A Personalized Approach

Allergic rhinitis can be a bothersome condition, but effective treatment options are available. This research emphasizes the importance of individualized treatment plans, considering the severity of AR, patient preferences, and the potential benefits and risks of different therapies. It's crucial to work closely with a healthcare professional to determine the most appropriate treatment approach for your individual needs.

Dr. Camel's Conclusion

The desert of allergic rhinitis can be filled with uncomfortable symptoms and a constant search for relief. This research offers a helpful guide to navigate the vast treatment landscape, providing insights into the effectiveness of different therapies. By understanding the individual characteristics of these treatments, we can find the oasis of symptom relief and improve our quality of life.

Date :
  1. Date Completed 2022-09-30
  2. Date Revised 2023-01-27
Further Info :

Pubmed ID

35567393

DOI: Digital Object Identifier

10.1111/all.15371

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.